Drug Analysis And Development Suppliers Near Israel

De-risk the development of novel therapies. Fueled by AI. Based on a unique wealth of proprietary and expertly curated data, Intelligencia has been pioneering the use of Machine Learning algorithms to assess, quantify, and reduce the risk of ...

SonALAsense’s ALA sonodynamic therapy (SDT) is well differentiated from the use of other forms of therapy which have been used for GBM or rGBM. Our use of a MRI-guided focused ultrasound device with ALA is a true drug-device combination, where both ...

We founded Hillhurst to liberate Sickle Cell Disease patients from the horrendous, recurrent, lifelong severe painful episodes and accompanying organ injury of this life limiting disease. We are a team of physicians, researchers, and drug ...

Urotronic is focused on developing Drug Coated Balloons which we believe are the future of interventional urology. Laborie Medical owns the global commercialization rights to Optilume Stricture. Optilum BPH is an investigational device in the United ...

Tris Pharma is a privately owned premier pharmaceutical company focused on commercializing our branded portfolio of differentiated ADHD medications, seeking development and licensing partnerships by leveraging our novel technology platform, and ...

VeriSIM was founded in 2017 by Dr. Jo Varshney, a multi-disciplinary and celebrated leader in veterinary & human health development. Together with a team of world-class scientists, machine learning engineers and in silico simulation experts the team ...

We are exploring sequence-based drug discovery and development, which is bypassing the need for 3D structure. ...

Founded in 2005, by Alexandre TOKAY, CEO, and Dr. Michel KHRESTCHATISKY, Scientific Advisor, VECT-HORUS is a spin-off of the NICN UMR7259 (CNRS and Aix-Marseille University) now Institute for NeuroPhysiopathology (INP) directed by Dr. Michel ...

At Alithea Genomics we are committed to developing solutions that simplify and streamline the generation of 'big RNA data', which we believe will constitute the foundation of tomorrow's research and medicine. Our technologies enable our clients to ...

Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug ...

Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and ...

Iktos was founded in 2016 by Quentin Perron, Nicolas Do Huu, and Yann Gaston-Mathé, with the aim of developing an innovative and user-friendly technology platform for deep-learning based de novo drug design, leveraging a proprietary algorithm ...

Founded in 2008, S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction in both women and men. The company’s non-hormonal therapies work uniquely by restoring the natural balance of neurotransmitters in the brain. ...

ReproNovo, established in 2021, is a company with a focus on reproductive medicine and women's health. The team, composed of experts with years of experience, is dedicated to developing innovative therapeutic solutions targeting male and female ...

With over 50 years of experience, we are a forward-thinking, North American CDMO specializing in clinical-to-commercial scale production of high-quality regulated APIs and Intermediates. BIOVECTRA is a North American CDMO specializing in ...

LayerBio, Inc. is clinical-stage biotechnology company developing innovative therapies to address unmet needs in the field of ophthalmology and other therapeutic areas. LayerBio was founded as a spinoff of Massachusetts Institute of Technology (MIT) ...

We are an interdisciplinary team with a focus on research, translation, clinical development, manufacturing, and commercialization. Our passionate team is committed to provide safe and effective tumor therapy. We are supported by a strong scientific ...

TIKOMED AB is a privately owned company based in Viken, Sweden. It is governed by the Laws of the Kingdom of Sweden and was formed in accordance with the Swedish Company Act in 2002. We develop and commercialize innovative treatments for patients ...

The volume of human molecular data is growing exponentially, but our analytic capabilities are growing linearly, at best. Humans alone cannot process all this data. What’s needed is a technology capable of digesting, organizing and making sense of ...

Founded in 2014, LCC is now established as one of the world’s most innovative CROs. We believe that curiosity driven by purpose leads to new ideas and faster progress. By offering improved access to 3D chemical space, we help to accelerate the ...